AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

6,525.00p
   
  • Change Today:
    124.00p
  • 52 Week High: 6,540.00
  • 52 Week Low: 4,760.00
  • Currency: UK Pounds
  • Shares Issued: 1,267.29m
  • Volume: 1,343,533
  • Market Cap: 82,690m
  • RiskGrade: 119
  • Beta: 0.00

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 3.3% 3.4%
Div Cover 1.2 1.3
Op Mrgn 16.1% 23.3%
ROCE 103.5%  
Latest F'cast
P/E 24.7 23.8
PEG n/a 6.9
Pr/Revenue 5.1 4.5
Pr/Book 7.7  
Latest F'cast
Revenue 4.5% -34.1%
PBT -10.5% 62.3%
EPS -19.2% 3.4%
DPS n/a -41.4%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 26,095.00 1,246.00 428.00¢ 14.0 n/a -15% 280.00¢ 4.7%
31-Dec-15 23,641.00 3,069.00 426.00¢ 14.2 n/a -0% 280.00¢ 4.6%
31-Dec-16 21,319.00 3,552.00 431.00¢ 13.5 13.5 +1% 280.00¢ 4.8%
31-Dec-17 20,152.00 2,227.00 428.00¢ 15.7 n/a -1% 280.00¢ 4.2%
31-Dec-18 21,049.00 1,993.00 346.00¢ 22.3 n/a -19% 280.00¢ 3.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 18,187.04 4,242.13 269.14p 24.2 7.1 +3% 215.10p 3.4%
31-Dec-20 20,011.19 4,898.81 329.93p 19.8 0.9 +23% 217.46p 3.5%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

US FDA grants saracatinib ODD for IPF 18-Mar-2019 07:00 RNS
Notice of AGM 14-Mar-2019 12:00 RNS
Director/PDMR Shareholding 12-Mar-2019 12:00 RNS

Latest AstraZeneca Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 6,525.00p
Change Today 124.00p
% Change 1.94 %
52 Week High 6,540.00
52 Week Low 4,760.00
Volume 1,343,533
Shares Issued 1,267.29m
Market Cap 82,690m
Beta 0.00
RiskGrade 119

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80.87% below the market average80.87% below the market average80.87% below the market average80.87% below the market average80.87% below the market average
3.45% below the sector average3.45% below the sector average3.45% below the sector average3.45% below the sector average3.45% below the sector average
Price Trend
92.03% above the market average92.03% above the market average92.03% above the market average92.03% above the market average92.03% above the market average
93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average93.33% above the sector average
Income
25.44% below the market average25.44% below the market average25.44% below the market average25.44% below the market average25.44% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
92.42% below the market average92.42% below the market average92.42% below the market average92.42% below the market average92.42% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 15
Buy 0
Neutral 9
Sell 1
Strong Sell 3
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 08-Aug-19 28-Feb-19
Paid 09-Sep-19 27-Mar-19
Amount 90.00¢ 190.00¢

Trades for 21-Mar-2019

Time Volume / Share Price
16:35 409,313 @ 6,525.00p
16:29 171 @ 6,528.00p
16:29 256 @ 6,529.00p
16:29 100 @ 6,530.00p
16:29 115 @ 6,530.00p

Top of Page